InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
60,890.66
(
0.96%
)
Post# of 252428
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Robert C Jonson

Send PM Follow Ignore
Followers 29
Posts 2135
Boards Moderated 0
Alias Born 10/28/2007

Robert C Jonson

Re: poorgradstudent post# 157432

Wednesday, 02/27/2013 9:05:32 AM

Wednesday, February 27, 2013 9:05:32 AM

Post# of 252428
Again, PGS, kudos to you for a fine post!

Nevertheless, I have an observation about tis comment of yours:

" I basically did everything in my power to ignore the clinical data and what it objectively said. "


To me, that's what the folks on this board are doing to PPHM's results in 2nd line NSCLC. The folks in the treatment arm have an MOS of 11.7 months, longer than any other trial to date. It seems to me BV folks are "ignoring the clinical data and what it objectively said," with exwannabe saying these people didn't really have cancer!

Sorry, I don't buy it.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up